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Abstract
Background: The yffB (PA3664) gene of Pseudomonas aeruginosa encodes an uncharacterized
protein of 13 kDa molecular weight with a marginal sequence similarity to arsenate reductase from
Escherichia coli. The crystal structure determination of YffB was undertaken as part of a structural
genomics effort in order to assist with the functional assignment of the protein.
Results:  The structure was determined at 1.0 Å resolution by single-wavelength anomalous
diffraction. The fold is very similar to that of arsenate reductase, which is an extension of the
thioredoxin fold.
Conclusion: Given the conservation of the functionally important residues and the ability to bind
glutathione, YffB is likely to function as a GSH-dependent thiol reductase.
Background
The  yffB  (PA3664) gene of Pseudomonas aeruginosa
encodes an uncharacterized protein of 13 kDa molecular
weight. Based on the amino acid sequence analysis, YffB
and its homologs have been assigned to the family of arse-
nate reductase (AR) and related proteins (Pfam entry
PF03960) [1]. AR participates in arsenic detoxification by
catalyzing the reduction of arsenate [the oxyanion of
As(V)] to arsenite [the oxyanion of As(III)], which is then
exported through a specific transport system [2]. There are
two different types of bacterial ARs. AR of Gram-negative
bacteria has a distinct HX3CX3R catalytic sequence motif,
belongs to the thioredoxin (Trx) structural superfamily,
and is coupled to the glutathione (GSH) and glutaredoxin
(Grx) system for its enzyme activity [3,4]. AR of Gram-
positive bacteria also has a redox active cysteine residue
but within a CX5R sequence motif embedded in a fold typ-
ical for low molecular weight protein tyrosine phos-
phatases, and requires Trx and Trx reductase for enzyme
activity [5-7].
Besides the Trx-like AR, the PF03960 family includes a
number of uncharacterized proteins whose function
seems unlikely to be arsenate reductase. Members of the
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family are widely represented in bacteria, but not in
archaea or eukaryotes. The pattern of amino acid distribu-
tion along the polypeptide chain suggests that these pro-
teins may have a common fold.
The crystal structure determination of YffB was under-
taken as part of a structural genomics effort [8] in order to
assist with the functional assignment of the protein. The
project was focused on the so-called hypothetical proteins
from Haemophilus influenzae. The YffB protein from P. aer-
uginosa has emerged as an ortholog of HI0103 to increase
chances for successful crystallization. YffB was cloned,
expressed, and the crystal structure determined at 1.0 Å
resolution. The protein fold appeared to be similar to that
of Escherichia coli AR. Analysis of the structure suggests
that YffB may function as a thiol reductase.
Results and discussion
The atomic model of YffB contains all residues but the N-
terminal methionine, which has probably been posttrans-
lationally cleaved. The molecular weight of the SeMet pro-
tein measured by matrix-assisted laser-desorption
ionization (MALDI) mass spectrometry was close to the
calculated value of 13,121 Da for residues 2–115. An
addition of one selenomethionine would have increased
the molecular weight by 178 Da.
The structure of YffB consists of two domains (Fig. 1). One
is formed by a four-stranded mixed β-sheet flanked by two
α-helices on one side. The other domain is an α-helical
bundle comprising residues 38–88. The overall fold is
very similar to AR from E. coli encoded by the arsC gene
[4]. The rms deviation between the structures is 2.3 Å for
all 109 common Cα atoms, the Z-score calculated by
DALI [9] is 12.6. Relative to YffB, ArsC has an additional
C-terminal domain, a 3-strand meander, that covers heli-
ces α1 and α7.
The α/β-domain is characteristic of a superfamily of the
Trx-like proteins [10]. Common to all of them, a cis-pro-
line residue is located at the N-terminus of strand β3. This
residue is important for the integrity of the active site, as
the cis-peptide bond promotes a turn of the polypeptide
chain. The corresponding Pro93 in YffB is also in the cis-
conformation.
The overall structural similarity to the members of the Trx
superfamily allows the identification of the putative active
site of YffB in the loop between the first β-strand and the
following α-helix. A cysteine residue at the N-terminus of
the α-helix acts as a catalytic nucleophile [10]. Its pK is
lowered by the basic environment and the dipole of the
helix [11]. In ArsC the thiol group of the cysteine attacks
the arsenic of the substrate to form a covalent intermedi-
ate [4]. The arsenite ion is released upon binding of GSH,
which is then reduced by Grx [3]. Unlike many Trx-like
proteins, the catalytic cysteine in ArsC does not form an
internal disulfide in the oxidized state. YffB also has only
one cysteine residue at the active site (Cys11), which fur-
ther emphasizes its similarity to ArsC and suggests that it
functions in a GSH-dependent manner.
Despite the structural similarity to ArsC, the two proteins
share only 16% identical residues. However, most of the
residues involved in substrate binding and catalysis are
conserved in these proteins. Three invariant arginine resi-
dues, Arg60, Arg94, and Arg107, bind the substrate and
stabilize the reaction intermediate in ArsC [12]. They may
also enhance the nucleophilicity of the active cysteine.
Arg94 together with the ensuing cis-Pro95 is conserved in
all AR-related proteins. Lys91 of YffB, despite its different
location in the sequence, is spatially equivalent to Arg60
of ArsC and therefore can take part in substrate binding.
The most important difference with respect to ArsC is the
substitution of Gly for Arg107 that leaves the binding site
without the positively charged anchor and also makes
Cys11 more accessible for bulky compounds. This substi-
tution probably reflects a difference in substrate specificity
between ArsC and YffB.
One particular consequence of this Arg to Gly replace-
ment might be the ability of YffB to bind GSH, whereas
ArsC cannot bind GSH in the absence of arsenate [13].
The binding of GSH to YffB was detected by MALDI mass
(Left) Ribbon presentation of the polypeptide fold of YffB Figure 1
(Left) Ribbon presentation of the polypeptide fold of YffB. 
Active site residues are shown as ball-and-stick models (pro-
duced with MOLSCRIPT [19]). (Right) Electrostatic surface 
potential calculated with GRASP [20]. Positive charges are 
blue and negative are red.BMC Structural Biology 2004, 4 http://www.biomedcentral.com/1472-6807/4/5
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spectrometry using an oxidized form of glutathione
(GSSG). The mass increase of about 300 Da indicated one
GSH molecule bound per protomer. This result supports
the contention that GSH is probably involved in the func-
tional cycle of YffB.
YffB has a very polarized distribution of charges over the
surface of the molecule. The active site area is thronged
with basic residues, as it is in ArsC, whereas the opposite
side of the molecule is predominantly negatively charged
(Fig. 1B). The positive electrostatic potential would cer-
tainly favor binding of anions.
Conclusion
Given the structural similarity to the Trx-like proteins and
particularly to ArsC, and the conservation of the function-
ally important residues, YffB is likely to function as a thiol
reductase. The nature of the substrate remains to be estab-
lished in further biochemical and biophysical studies.
These studies will be facilitated by the three-dimensional
structure of the protein.
Methods
Cloning, expression and purification
The  yffB  (PA3664) gene from Pseudomonas aeruginosa
PAO1 was amplified using PfuTurbo  DNA polymerase
(Stratagene), genomic DNA (ATCC 47085D), and the fol-




The sequence encoding the thrombin cleavage site is
underlined, and the NdeI restriction site is shown in italic.
The PCR product was introduced into a pET100/D-TOPO
expression vector by the TOPO directional cloning proce-
dure (Invitrogen). Recombinant plasmids were isolated
from the E. coli TOP10 strain. The expression construct for
production of the native protein without a His-tag was
prepared by digestion with NdeI and self ligation. For pro-
duction of the selenomethionine (SeMet) protein, E. coli
strain B834 (DE3) was transformed with the recombinant
plasmid, and cells were grown in a minimal medium sup-
plemented with 100 µg/mL ampicillin and 40 µg/mL
SeMet until the A600 reached 0.8. At this point the cells
were induced with 1 mM isopropyl β-D-thiogalactoside
and harvested after 3 h.
The SeMet protein was purified by column chromatogra-
phy in three steps. The cell extract was applied to a Q
Sepharose HP (Pharmacia) column equilibrated with 20
mM HEPES (pH 6.7), 50 mM NaCl, and 0.5 mM EDTA.
About half of the protein bound to the column and was
eluted in a 50–500 mM NaCl gradient. After dialysis in 20
mM HEPES (pH 6.7) and 0.5 mM EDTA, the fractions
containing the protein were applied to a Source 15S
(Pharmacia) column, and eluted with a 0–450 mM NaCl
gradient. The protein was concentrated to 4 mg/ml,
applied to a Sephacryl S100 (Pharmacia) gel filtration col-
umn, and eluted in 20 mM HEPES (pH 7.5), 100 mM
NaCl, and 0.25 mM EDTA. According to the SDS gel, the
protein was at least 95% pure. For crystallization, the pro-
tein was concentrated to 15 mg/ml.
Crystallization and structure determination
YffB crystals were grown by the vapor diffusion hanging
drop method at room temperature from 0.1 M CHES, pH
10, 26% polyethylene glycol 3350, and 5% isopropanol.
They belong to the space group C2 with unit cell parame-
ters: a = 87.45 Å, b = 43.25 Å, c = 29.06 Å, β = 93.5°. There
is one protein molecule in the asymmetric unit with the
solvent content of 40%. For X-ray data collection, the crys-
tals were soaked in the mother liquor supplemented with
15% polyethylene glycol 400 and flash-frozen in liquid
propane.
The structure was solved by using single-wavelength
(0.9794 Å) anomalous X-ray diffraction data collected on
the NCI-NIH beamline at the National Synchrotron Light
Source (Upton, NY). The data (Table 1) were processed
with HKL2000 [14]. Two selenium sites were located by
SHELXD and were used for phasing with SHELXE [15].
The polypeptide chain was automatically traced with
RESOLVE [16]. The atomic model was completed using O
[17] and refined with REFMAC [18] using anisotropic B-
factors. The model includes residues 2–115 of the protein,
a molecule of isopropanol, and 220 water molecules. 93%
residues have main-chain torsion angles in the most
favored conformation.
The atomic coordinates of YffB and structure factors were
deposited in the Protein Data Bank under the accession
code 1RW1.
Glutathione binding
Binding of glutathione was detected by MALDI mass spec-
trometry using a Voyager spectrometer (Applied Biosys-
tems, Foster City, CA). The SeMet protein (10 µM) was
incubated for 1 h at room temperature with 1 mM GSSG
in 20 mM HEPES buffer, pH 7.The sample was mixed 1:1
with matrix solution (10 mg/mL 3,5-dimethoxy-4-
hydroxycinnamic acid, 50% aqueous acetonitrile, and
0.2% trifluoroacetic acid), deposited onto a golden plate,
and allowed to dry at room temperature. Bovine
myoglobin was used for molecular mass calibration.BMC Structural Biology 2004, 4 http://www.biomedcentral.com/1472-6807/4/5
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Table 1: X-ray data and refinement statistics.
Resolution (Å) 30-1.02 (1.04-1.02)1
Number of unique reflections2 98,866 (5,709)
Completeness (%) 91.2 (92.3)
Redundancy 3.9 (3.7)
Rsym (Σ|I-<I>|)/ΣI) 0.051 (0.419)
<I/σ> 22.0 (3.6)
Fraction of refls with I>3σ (%) 81.6 (50.2)
Rcryst (Σ||Fo|-|Fc||)/Σ|Fo|) 0.129 (0.155)
Rfree (2% data) 0.139 (0.202)
Number of protein non-hydrogen atoms 935
Number of water molecules 220
Mean B-factor from the model (Å2)1 0 . 4
Mean B-factor from Wilson plot (Å2)8 . 1
RMSD in bonds (Å) 0.011
RMSD in angles (°) 1.3
RMSD in main-chain B factors (Å2)2 . 1
1Data for the highest resolution shell are given in parentheses 2Anomalous pairs not merged